TY - JOUR
T1 - Pathologic response to preoperative therapy
T2 - Does it mean what we think it means?
AU - Mansour, John C.
AU - Schwarz, Roderich E.
N1 - Funding Information:
ACKNOWLEDGMENT This project was supported in part by the NIH UL1 RR024982 grant.
PY - 2009/6
Y1 - 2009/6
N2 - Tumors treated with preoperative chemotherapy or radiation often demonstrate evidence of response in the resection specimen. Pathologic response is often interpreted as a surrogate for recurrence or survival outcomes. With a valid surrogate for long-term outcomes, investigators can explore treatment strategies with immediate endpoints. The financial and time costs of trials measuring recurrence and survival may be lessened by using short-term pathologic outcomes as an endpoint. This review is intended to examine the current status of pathologic response as a surrogate for tumor behavior. We address questions regarding the definitions of pathologic response, as well as the current literature regarding the meaning of pathologic response for some common tumor types. We explore some of the potential confounding effects that may explain the frequent discordance between tumor response and patient outcomes. In addition, we address some alternative strategies to gauge the response of a tumor to preoperative therapy.
AB - Tumors treated with preoperative chemotherapy or radiation often demonstrate evidence of response in the resection specimen. Pathologic response is often interpreted as a surrogate for recurrence or survival outcomes. With a valid surrogate for long-term outcomes, investigators can explore treatment strategies with immediate endpoints. The financial and time costs of trials measuring recurrence and survival may be lessened by using short-term pathologic outcomes as an endpoint. This review is intended to examine the current status of pathologic response as a surrogate for tumor behavior. We address questions regarding the definitions of pathologic response, as well as the current literature regarding the meaning of pathologic response for some common tumor types. We explore some of the potential confounding effects that may explain the frequent discordance between tumor response and patient outcomes. In addition, we address some alternative strategies to gauge the response of a tumor to preoperative therapy.
UR - http://www.scopus.com/inward/record.url?scp=67349083499&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=67349083499&partnerID=8YFLogxK
U2 - 10.1245/s10434-009-0374-z
DO - 10.1245/s10434-009-0374-z
M3 - Review article
C2 - 19326170
AN - SCOPUS:67349083499
SN - 1068-9265
VL - 16
SP - 1465
EP - 1479
JO - Annals of Surgical Oncology
JF - Annals of Surgical Oncology
IS - 6
ER -